Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 1-5 of 5 (Search time: 0.008 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
7-Apr-2022MEK and MCL-1 sequential inhibition synergize to enhance rhabdomyosarcoma treatmentAlcón, Clara; Martín, Fernando; Prada, Estela; Mora, Jaume; Soriano, Aroa; Guillén, Gabriela; Gallego, Soledad; Roma, Josep; Samitier i Martí, Josep; Villanueva, Alberto; Montero, Joan
9-Sep-2021MCL-1 Inhibition Overcomes Anti-apoptotic Adaptation to Targeted Therapies in B-Cell Precursor Acute Lymphoblastic LeukemiaManzano Muñoz, Albert; Alcón, Clara; Menéndez, Pablo; Ramírez, Manuel; Seyfried, Felix; Debatin, Klaus-Michael; Meyer, Lüder H.; Samitier i Martí, Josep; Montero, Joan
15-Aug-2020Sequential combinations of chemotherapeutic agents with BH3 mimetics to treat rhabdomyosarcoma and avoid resistanceAlcón, Clara; Manzano Muñoz, Albert; Prada, Estela; Mora Salvador, Jaume; Soriano, Aroa; Guillén, Gabriela; Gallego, Soledad; Roma, Josep; Samitier i Martí, Josep; Villanueva Garatachea, Alberto; Montero, Joan
2-Jul-2021ER+ Breast Cancer Strongly Depends on MCL-1 and BCL-xL Anti-Apoptotic ProteinsAlcón, Clara; Gómez Tejeda Zañudo, Jorge; Albert, Reka; Wagle, Nikhil; Scaltriti, Maurizio; Anthony, Letai; Samitier i Martí, Josep; Montero, Joan
12-Mar-2023Quantitative image analysis of fibrillar collagens reveals novel diagnostic and prognostic biomarkers and histotype-dependent aberrant mechanobiology in lung cancerAlmici, Enrico; Arshakyan, Marselina; Carrasco Jordan, Josep Lluís; Martínez, Andrea; Ramírez Ruz, J. (José); Enguita, Ana Belén; Monsó, Eduard; Montero, Joan; Samitier i Martí, Josep; Alcaraz Casademunt, Jordi